Genes and immune system in pediatric catatonia
Part of Brain & nervous system clinical trials.
This study looks at the immune system and genes of children and teens with catatonia. It aims to find out what causes catatonia and may help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The child or teen must be 0 to 17 years old and have a diagnosis of catatonia.
- Biological parents or genetically related family members can also take part to help with genetic testing.
- The child cannot have already had whole genome or exome sequencing.
- The family must be reachable and able to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often catatonic syndrome occurs in adults treated at Basurto Hospital, what other conditions it's linked to, and what happens in the short term. It helps doctors better understand this serious condition.
This study looks at many types of tests (including genetic testing and other lab data) to help understand what may be causing first-time psychosis symptoms in youth. It may help doctors learn more about the condition for future care, and it can involve analyzing family genetic information.
This study looks at genetic (DNA) information to understand mental health crises in youth with intellectual and developmental disabilities. It may help doctors learn why these crises happen and improve how future families are supported.
This study uses trio genome sequencing (comparing DNA from you and both of your parents) to find genetic causes for psychiatric disorders that start early, are hard to treat, or have an unusual pattern. It may help if you or your child have a mental health condition without intellectual disability or birth defects.
This study looks for genetic causes of immune problems, such as unusually frequent infections, abnormal allergies, or autoimmune or inflammation conditions. It may help by improving how doctors understand these disorders and by matching families with possible genetic diagnoses.
This study looks at the genetic and molecular profiles of children with autism spectrum disorder (ASD) to better understand the condition and find new treatments. It compares children with ASD who have no known genetic cause to those with a specific genetic syndrome.
Hear when a new Catatonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.